ANGIODYNAMICS INC (ANGO) Stock Price, Quote, News and Overview
NASDAQ:ANGO - Nasdaq - US03475V1017 - Common Stock
ANGO Quote and Key Statistics
ANGIODYNAMICS INC
NASDAQ:ANGO (1/21/2025, 8:00:00 PM)
After market: 11.8 -0.14 (-1.17%)11.94
-0.49 (-3.94%)
ANGO Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -77.08% | ||
| ROE | -120.32% | ||
| Debt/Equity | 0 |
ANGO Performance and Technical Analysis
ANGO Ownership and Analysts
ANGO Latest News and Analysis
Top movers in Wednesday's session
Stay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
The market is filled with gapping stocks in Wednesday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Let's delve into the US markets on Wednesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
About ANGO
Company Profile
AngioDynamics, Inc. operates as a medical device company, which engages in the development, manufacturing and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 748 full-time employees. The company went IPO on 2004-05-27. The firm is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. The company designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Company Info
ANGIODYNAMICS INC
14 Plaza Drive
Latham NEW YORK 12110 US
CEO: James C. Clemmer
Employees: 748
Company Website: https://www.angiodynamics.com/
Investor Relations: https://investors.angiodynamics.com/?us
Phone: 15187981215
ANGO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 89.9 | 215.18B | ||
| ABT | ABBOTT LABORATORIES | 25.84 | 202.57B | ||
| SYK | STRYKER CORP | 34.01 | 150.91B | ||
| BSX | BOSTON SCIENTIFIC CORP | 42.76 | 148.72B | ||
| MDT | MEDTRONIC PLC | 16.83 | 113.33B | ||
| BDX | BECTON DICKINSON AND CO | 18.27 | 69.71B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.21 | 41.27B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.7 | 39.90B | ||
| RMD | RESMED INC | 29.89 | 36.38B | ||
| IDXX | IDEXX LABORATORIES INC | 39.03 | 34.99B | ||
| DXCM | DEXCOM INC | 50.78 | 33.72B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 19.98 | 24.97B |